|
| Monday, 27 July 2020, 17:26 HKT/SGT | |
| |
|
|
|
|
Mobile PCR Lab Specially Developed for COVID-19 Testing
Delivered to Shanghai Pudong Airport for Arrival Testing |
HONG KONG, July 27, 2020 - (ACN Newswire) - World-leading container manufacturer and logistics services provider Singamas Container Holdings Limited ("Singamas" / the "Group") (stock code: 716) has announced today that it has delivered a mobile Polymerase Chain Reaction ("PCR") laboratory for COVID-19 testing to the Shanghai Pudong Airport on 8 July 2020. The mobile laboratory can handle a maximum of 1,500 specimens a day. It consists of three functional rooms including the reagent preparation room, specimen processing room and PCR test room. Arrival testing will be commenced this week.
The mobile PCR laboratory has been developed by the Group's in-house R&D team located in Shanghai, the PRC, together with experts from the renowned Chinese Academy of Sciences and China Customs. Engineers from the Group's R&D team are dedicated to the research and development of advanced customised specialised containers meeting the needs of society as well as the demands from customers around the world. Apart from specialised transportation-focused containers, the Group's R&D team has been developing containers for use in a wide range of areas including but not limited to power generation, energy storage, data centres, housing and hotel, pressurized ex-proof, breeding and farming, as well as for scientific and medical applications.
Mr. Teo Siong Seng, Chairman of Singamas, said: "We are very excited about the development of the mobile PCR laboratory for the Shanghai Pudong Airport, and would like to thank the local government for entrusting us with this important responsibility for the city. As Singamas' specialised containers business develops, we are fascinated that when combined with modern technology, our products can be developed for diverse segments with diverse needs. With the support of our dedicated R&D team, superb manufacturing skills, and the trust and confidence of our customers, we have already developed over 1,000 types of specialised products to date. Moving forward, we are well-equipped to strengthen our product innovation and offer a comprehensive range of products to satisfy the specific needs of our community."
About Singamas Container Holdings Limited
Singamas is one of the world's major container manufacturers and logistics services providers. Its manufacturing business covers container factories located in Mainland China that focus on the manufacturing, R&D and sale of dry freight and specialised containers. Its logistics operations include container depots located in key locations in Mainland China and in Hong Kong, as well as a logistics company in Xiamen. Riding on its comprehensive investment strategies, the Group is consolidating its market leadership in the global container industry. For details, please visit: www.singamas.com.
Topic: Press release summary
Sectors: Daily Finance, Daily News
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Fujitsu introduces biometric authentication service for SMBC Nikko Securities Online Trading
Monday, February 2, 2026 1:30:00 PM
|
|
|
COSMOPlat, Serving 160,000 Firms, Files for Hong Kong IPO on "AI+Industrial Internet" Wave
Feb 2, 2026 13:29 HKT/SGT
|
|
|
Muyuan Foods IPO: Hog Giant's Profit Growth Outpaces Top 10 Global Meat Firms, Eyes Global Expansion
Feb 2, 2026 13:17 HKT/SGT
|
|
|
JCB Launches Usage Promotion Campaign for Inbound Visitors in Fukuoka's Tenjin Area
Monday, February 2, 2026 9:00:00 AM
|
|
|
Web-based tool makes it easier to design advanced materials 
Feb 2, 2026 08:00 HKT/SGT
|
|
|
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets
Feb 1, 2026 17:00 HKT/SGT
|
|
|
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre
Jan 31, 2026 21:00 HKT/SGT
|
|
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT/SGT
|
|
|
NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion
Friday, January 30, 2026 9:50:00 PM
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
 |
|
 |
|
